Dr. Christoph Zehe holds a doctoral degree in molecular and cell biology from the University of Heidelberg (2007). In 2007, he joined Cellca GmbH and developed Cellca’s proprietary expression system. Furthermore, he established one of the most competitive platform processes for the generation of high-expressing production cell lines on the market. In 2014, Dr. Zehe was appointed as Head of Technology Development and is now in charge of all product development and improvement activities at Cellca.